283 related articles for article (PubMed ID: 22097147)
1. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study.
Zeitels SM; Barbu AM; Landau-Zemer T; Lopez-Guerra G; Burns JA; Friedman AD; Freeman MW; Halvorsen YD; Hillman RE
Ann Otol Rhinol Laryngol; 2011 Oct; 120(10):627-34. PubMed ID: 22097147
[TBL] [Abstract][Full Text] [Related]
2. Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis.
Zeitels SM; Lopez-Guerra G; Burns JA; Lutch M; Friedman AM; Hillman RE
Ann Otol Rhinol Laryngol Suppl; 2009 Sep; 201():1-13. PubMed ID: 19845188
[TBL] [Abstract][Full Text] [Related]
3. Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosis.
Best SR; Friedman AD; Landau-Zemer T; Barbu AM; Burns JA; Freeman MW; Halvorsen YD; Hillman RE; Zeitels SM
Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):587-93. PubMed ID: 23012897
[TBL] [Abstract][Full Text] [Related]
4. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience.
Maturo S; Hartnick CJ
Arch Otolaryngol Head Neck Surg; 2010 Jun; 136(6):561-5. PubMed ID: 20566906
[TBL] [Abstract][Full Text] [Related]
5. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
[TBL] [Abstract][Full Text] [Related]
6. Photoangiolytic laser treatment of early glottic cancer: a new management strategy.
Zeitels SM; Burns JA; Lopez-Guerra G; Anderson RR; Hillman RE
Ann Otol Rhinol Laryngol Suppl; 2008 Jul; 199():3-24. PubMed ID: 18710131
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis.
Hung WC; Lo WC; Fang KM; Cheng PW; Wang CT
Ann Otol Rhinol Laryngol; 2021 Apr; 130(4):363-369. PubMed ID: 32847376
[TBL] [Abstract][Full Text] [Related]
8. Office-based potassium titanyl phosphate laser-assisted endoscopic vocal polypectomy.
Wang CT; Huang TW; Liao LJ; Lo WC; Lai MS; Cheng PW
JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):610-6. PubMed ID: 23787420
[TBL] [Abstract][Full Text] [Related]
9. Voice outcomes for photoangiolytic KTP laser treatment of early glottic cancer.
Friedman AD; Hillman RE; Landau-Zemer T; Burns JA; Zeitels SM
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):151-8. PubMed ID: 23577566
[TBL] [Abstract][Full Text] [Related]
10. Effect of vocal fold injection of cidofovir and bevacizumab in a porcine model.
Connor MP; Brown A; Palazzolo M; Kunkel J; Eller R; Hartnick C; Maturo S
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):155-9. PubMed ID: 24288019
[TBL] [Abstract][Full Text] [Related]
11. The Use of 532-Nanometer-Pulsed Potassium-Titanyl-Phosphate (KTP) Laser in Laryngology: A Systematic Review of Current Indications, Safety, and Voice Outcomes.
Lechien JR; Burns JA; Akst LM
Ear Nose Throat J; 2021 Feb; 100(1_suppl):4S-13S. PubMed ID: 31928082
[TBL] [Abstract][Full Text] [Related]
12. Pulsed angiolytic laser treatment of ectasias and varices in singers.
Zeitels SM; Akst LM; Bums JA; Hillman RE; Broadhurst MS; Anderson RR
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):571-80. PubMed ID: 16944655
[TBL] [Abstract][Full Text] [Related]
13. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
Rogers DJ; Ojha S; Maurer R; Hartnick CJ
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):496-501. PubMed ID: 23681032
[TBL] [Abstract][Full Text] [Related]
14. 532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia.
Burns JA; Zeitels SM; Akst LM; Broadhurst MS; Hillman RE; Anderson R
Laryngoscope; 2007 Aug; 117(8):1500-4. PubMed ID: 17585283
[TBL] [Abstract][Full Text] [Related]
15. Effect of the 532nm pulsed KTP laser in the treatment of Reinke's edema.
Pitman MJ; Lebowitz-Cooper A; Iacob C; Tan M
Laryngoscope; 2012 Dec; 122(12):2786-92. PubMed ID: 22886907
[TBL] [Abstract][Full Text] [Related]
16. Surgical Outcome of Potassium-Titanyl-Phosphate (KTP) Laser Photocoagulation for Vocal Fold Vascular Lesions.
Balouch B; Yeakel H; Alnouri G; Brennan M; Martha V; Sataloff RT
J Voice; 2023 Sep; 37(5):790-797. PubMed ID: 34176682
[TBL] [Abstract][Full Text] [Related]
17. Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation of Utility in a Typical Clinical Practice.
Hall SR; Thiriveedi M; Yandrapalli U; Zhang N; Lott DG
Ann Otol Rhinol Laryngol; 2021 Oct; 130(10):1164-1170. PubMed ID: 33648353
[TBL] [Abstract][Full Text] [Related]
18. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Bentley PL; Coulter MJ; Nelson BL
Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
[TBL] [Abstract][Full Text] [Related]
19. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia.
Zeitels SM; Akst LM; Burns JA; Hillman RE; Broadhurst MS; Anderson RR
Ann Otol Rhinol Laryngol; 2006 Sep; 115(9):679-85. PubMed ID: 17044539
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
Karnezis TT; Davidson TM
Laryngoscope; 2011 Mar; 121(3):636-8. PubMed ID: 21344445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
